The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

As part of the ongoing transformation of its pharmaceutical business, Bayer has made significant investments in R&D to ...

Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy: Our Bureau, Bengaluru Wednesday, April 2, 2025, 14:50 Hrs [IST] Bayer Ph ...

TableSprint’s breakthrough innovation is its AI Consult system, which Kumar describes as an analyst, developer and cloud ...

The search for the shy and elusive dog has been something of a painstaking, trust-building exercise for those trying to bring ...

Bayer eyes launch of menopause relief, heart drugs this year Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 ...

Bayer Leverkusen's dream of a DFB Pokal double was dealt a surprising blow with a 2-1 defeat to Bundesliga 3 side Arminia ...

Bayer Leverkusen Targets Defender Latiu as Flinkpong's Departure Triggers Transfer Storm!

Li Qi, vice president of Bayer Pharmaceuticals and head of the Beijing R&D Center and Regulatory Affairs of China, and Professor Wang Hongwei, vice-president of Tsinghua University, present the Bayer ...

Frankfurt, Germany, July 16--Bayer AG will spin off its Lanxess chemicals and polymers unit to shareholders and list it separately on the stock exchange at the beginning of next year, the German ...